hotspot -WSS

hotspot

author：fashion 2025-10-01 22:39:22 - browse：5

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： 7 more heat

WSS

Winning ticket for $1 billion Powerball jackpot sold in California

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Dark money group runs ads on China biotech bill

Hospitals struggle to profit from CAR

Mass General totes up its waste in a move to tackle climate change

Antibiotic resistance nearly killed me, so I'm raising awareness of it

explore

hotspot

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Texas Department of Public Safety speaks out on migrant abuse allegations

Anesthesiologist group: stop taking Ozempic before surgery

Do more moles mean more problems? Not so, says new study

Walensky prepares to leave CDC — and Congress — behind

Affordable Connectivity Program vital to health care, experts say

Hepatitis C has a cure — but many Americans still lack access to it

Scientists successfully use ultrasound imaging to map brain activity

BioMarin wins approval for gene therapy to treat hemophilia A

Hospitals struggle to profit from CAR

hotspot

Heat waves linked to early deliveries, preterm births in new study

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Hospitals struggle to profit from CAR

Do more moles mean more problems? Not so, says new study

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Health insurers say they are turning to AI to cut costs, improve care

knowledge

leisure time

knowledge

focus